Oxford Science Enterprises
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Mirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
Mirae is a continuous care platform for autoimmune disease and other complex chronic conditions, initially focused on inflammatory bowel disease. Conversational AI collects the symptoms, daily behaviours, medications and changes patients describe in plain language, and converts them into a structured view of the disease that clinicians can act on at the point of care.
Moa Technology unlocks £22m Series C led by Oxford Science Enterprises and Supernova to help farmers protect their harvests from crop-killing weeds
Moa Technology is an agricultural biotechnology business that discovers herbicides with novel modes of action. Its GALAXY screening platform identifies chemistry that kills weeds through mechanisms existing products do not use, giving crop protection companies and the farmers they supply a way to control weeds that have stopped responding to current treatments.
RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
RQ Bio is a UK-based biotechnology company developing long-acting monoclonal antibodies against seasonal influenza. Its lead programme, RQB01, is designed to deliver potent, broad-strain protection against influenza through a dual mechanism of action, targeting patients whose immune systems cannot rely on vaccination alone.
Caudal Energy raises £4.3m in funding led by Oxford Science Enterprises and Empirical Ventures to develop predictable tidal power technology
Caudal Energy develops fin-based tidal power systems designed to generate predictable renewable electricity from mid-flow tidal sites. The Oxford spinout is building modular infrastructure intended to reduce deployment complexity and expand where tidal energy can be commercially viable.
Ascension secures £1.7m in funding from UKI2S and Innovate UK to tap geothermal critical mineral reserves
Ascension develops technology to recover critical minerals from underground geothermal systems. It enables extraction from volcanic rock deposits without surface mining, reducing environmental impact and reliance on concentrated supply chains.
Archangel Lightworks raises £10m Series A led by Santander Alternative Investments for space-to-ground laser communications
Archangel Lightworks builds laser communication systems that connect space-based networks with infrastructure on the ground. Its deployable optical ground station enables high-speed, secure data transfer for applications such as connectivity, monitoring, and communications.
Stateful Robotics raises a £3.6m pre-seed led by Amadeus Capital Partners and Oxford Science Enterprises to help robots operate reliably in the real world
Stateful Robotics develops software that helps robots plan and operate reliably in real-world environments. It provides a system that tracks past activity and performance so robots can adapt to changing conditions and complete tasks over time.
Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs
Allos AI applies causal AI to reformulate complex generic drugs, improving delivery, tolerability and predictability while reducing development uncertainty.
Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery
Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.
Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species
Wild Bio applies AI and precision breeding to crop genetics, using insights from wild plant species to develop climate-resilient, higher-yield crop varieties for commercial agriculture.
Kneu Health raises £4m seed round co-led by Oxford Science Enterprises and Cedars-Sinai to scale precision neurology platform
Kneu Health develops a precision neurology platform that uses smartphone-based data and clinically trained AI models to monitor Parkinson’s and dementia continuously, supporting earlier intervention and more proactive neurological care.
Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US
Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.
NavLive raises £4m seed round led by OSE to launch real-time AI scanner for architecture and construction
NavLive develops a handheld AI-powered scanning device that creates real-time, high-precision building surveys, enabling architects and construction teams to generate instant 2D and 3D models on site.
Neu Health raises £1.6m from Cedars-Sinai and Oxford Science Enterprises to expand neurology care platform
Neu Health provides a digital care platform for neurological conditions, enabling continuous patient monitoring and personalised care plans to support people living with Parkinson’s and dementia.
More venture news
- 6 Aug 2026
Naked EnergyNaked Energy raises £9m led by Great British Energy to open a UK factory for its solar-thermal panels
EquityEnergy - 5 Aug 2026
Sorted TechnologiesSorted Technologies raises £920k in funding from Green Angel Ventures and Archipelago Ventures for low-cost robotics that automate waste sorting in recycling facilities
EquityIndustrial - 5 Aug 2026
VisaDocVisaDoc secures a six-figure investment from Mercia to automate the visa process for business travellers
EquityLegal
